Showing results (151-160 of 180) with videos related to

Sort By:
Pageof 18
Journal of Geriatric Oncology|April 22, 2022
Integrating geriatric assessment and genetic profiling to personalize therapy selection in older adults with acute myeloid leukemiaVijaya R Bhatt, Christopher Wichman, Zaid S Al-Kadhimi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 19, 2019
Summary of the Third Annual Blood and Marrow Transplant Clinical Trials Network Myeloma Intergroup Workshop on Minimal Residual Disease and Immune ProfilingSarah A Holstein, Zaid Al-Kadhimi, Luciano J Costa, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 16, 2017
BMT CTN Myeloma Intergroup Workshop on Minimal Residual Disease and Immune Profiling: Summary and Recommendations from the Organizing CommitteeSarah A Holstein, Hervé Avet-Loiseau, Theresa Hahn, et al.
Blood Advances|January 4, 2018
Immune signatures associated with improved progression-free and overall survival for myeloma patients treated with AHSCTChristine M Ho, Philip L McCarthy, Paul K Wallace, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 24, 2020
Long-Term Follow-up of CALGB (Alliance) 100001: Autologous Followed by Nonmyeloablative Allogeneic Transplant for Multiple MyelomaSarah A Holstein, Vera J Suman, Kouros Owzar, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 9, 2018
Summary of the Second Annual BMT CTN Myeloma Intergroup Workshop on Minimal Residual Disease and Immune ProfilingSarah A Holstein, J Christine Ye, Alan Howard, et al.
Future Oncology (London, England)|February 17, 2023
A plain language summary of daratumumab plus lenalidomide/bortezomib/dexamethasone in transplant-eligible Black patients with newly diagnosed multiple myeloma in the GRIFFIN studyAjay K Nooka, Jonathan L Kaufman, Cesar Rodriguez, et al.
British Journal of Haematology|December 23, 2016
Phase 2 study of tabalumab, a human anti-B-cell activating factor antibody, with bortezomib and dexamethasone in patients with previously treated multiple myelomaNoopur S Raje, Philippe Moreau, Evangelos Terpos, et al.
Transplantation and Cellular Therapy|January 21, 2023
Ethical Challenges with Multiple Myeloma BCMA Chimeric Antigen Receptor T Cell Slot Allocation: A Multi-Institution ExperienceTaxiarchis Kourelis, Radhika Bansal, Jesus Berdeja, et al.
JTCVS Open|April 10, 2026
Liver disease severity score predicts early and late mortality after lung transplantation: A United Network for Organ Sharing database analysisStephanie K Tom, Rachel A Holstein, Clayton J Rust, et al.
Pageof 18